evonetix

Evonetix is a biotechnology startup company that aims to revolutionize synthetic biology by developing a novel platform for the precise synthesis of DNA at scale. The company's technology combines microfluidics, electronic control systems, and advanced chemistry to enable the parallel assembly of many overlapping oligonucleotides into long, error-free strands of DNA. This approach has the potential to significantly reduce the time and cost of creating custom DNA sequences for research, drug development, and other applications. Evonetix is based in Cambridge, UK, and has attracted funding from leading investors and partnerships with key industry players.